EUVIMEDEUVIMED entdecken
Crossref

Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer Immunity

Qinyanqiu Xiang, Xue Yang, Zhiqi Zhang, Jie Yang, Yingbo Li, Jiawei Du, Jue Wang, Kai Fan, Jiaxin Yuan, Jianqiong Zhang, Jinbing Xie, Shenghong Ju iD

Advanced Materials · 2025

DOI: 10.1002/adma.202419120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Qinyanqiu Xiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Department of Radiology, Z…. Hauptthemen laut MEDLINE: Adenosine, Breast Neoplasms, Iron, Lipid Peroxidation. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Jiangsu Excellent Postdoctoral Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD)‐mediated immunization strategies have great potential against breast cancer. However, traditional strategies neglect the increase in the immunosuppressive metabolite, adenosine (ADO), during ICD, leading to insufficient therapeutic outcomes. In this study, it is found that the adenosine A2A receptor (A2AR) is significantly expressed in breast cancer and positively associated with regulatory T (Treg) cells. Herein, a strategy combining Fe/Mo‐based lipid peroxidation (LPO) nanoamplifiers and A2AR blockade is reported to maximize ICD‐mediated anti‐tumor immunity. This LPO nanoamplifier causes LPO explosion by the Fe (II)‐mediated Fenton reaction and Mo(V)‐mediated Russell mechanism. Subsequently, it elicits the ICD magnification of tumor cells by inducing multiple regulated cell death patterns of ferroptosis, apoptosis, and necroptosis. Additionally, the A2AR antagonist (SCH58261), an immunometabolic checkpoint blocker, is found to relieve ADO‐related immunosuppression, amplify anti‐tumor immunological effects, and elicit immune memory responses. This robust anti‐tumor immunity is observed in primary, distant, pulmonary metastatic, and recurrent tumors. This study provides a novel strategy for optimizing ICD‐mediated immunotherapy and highlights the benefits of combining LPO explosion with A2AR blockade to enhance breast cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineBreast NeoplasmsIronLipid PeroxidationAnimalsFemaleHumansReceptor, Adenosine A2ACell Line, TumorMiceImmunogenic Cell DeathFerroptosisApoptosisAdenosine A2 Receptor AntagonistsTriazolesImmunotherapy

Stichwörter der Autor:innen

adenosine A2A receptoradenosine immunometabolismimmunogenic cell deathiron molybdate nanoparticleslipid peroxidation

Substanzen

AdenosineIronReceptor, Adenosine A2AAdenosine A2 Receptor AntagonistsTriazoles

Autor:innen und Institutionen

  • Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Department of Radiology, Zhongda Hospital, Medical School, Southeast University, 87 DingJiaQiao…
  • Department of Microbiology and Immunology, Medical School, Southeast University, Nanjing, 210009, P. R. China.

ORCID-Profile: Shenghong Ju

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Jiangsu Excellent Postdoctoral Program
  • National Postdoctoral Funding Program
  • Natural Science Foundation of Jiangsu Province
  • National Key Research and Development Program of China

Zitieren

APA

Xiang, Q., Yang, X., Zhang, Z., Yang, J., Li, Y., Du, J., Wang, J., Fan, K., Yuan, J., Zhang, J., Xie, J., & Ju, S. (2025). Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer Immunity. Advanced Materials. https://doi.org/10.1002/adma.202419120

Vancouver

Xiang Q, Yang X, Zhang Z, Yang J, Li Y, Du J, et al. Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer Immunity. Advanced Materials. 2025. doi:10.1002/adma.202419120

BibTeX
@article{Xiang2025,
  author = {Xiang, Qinyanqiu and Yang, Xue and Zhang, Zhiqi and Yang, Jie and Li, Yingbo and Du, Jiawei and Wang, Jue and Fan, Kai and Yuan, Jiaxin and Zhang, Jianqiong and Xie, Jinbing and Ju, Shenghong},
  title = {Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer Immunity},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202419120}
}
Kostenlos starten →